Yeoh K, Tan P
Nat Rev Cancer. 2021; 22(2):71-84.
PMID: 34702982
DOI: 10.1038/s41568-021-00412-7.
Adekunle O, Dretler A, Kauffman R, Cho A, Rouphael N, Wrammert J
PLoS Negl Trop Dis. 2021; 15(9):e0009743.
PMID: 34478460
PMC: 8445443.
DOI: 10.1371/journal.pntd.0009743.
Blachman U, Graboff S, Haag G, Gottfeld E, Pickett M
Infect Immun. 1974; 10(5):1098-104.
PMID: 16558096
PMC: 423068.
DOI: 10.1128/iai.10.5.1098-1104.1974.
Pierce N, Cray Jr W, ENGEL P
Infect Immun. 1980; 27(2):632-7.
PMID: 7380543
PMC: 550811.
DOI: 10.1128/iai.27.2.632-637.1980.
Majumdar A, Dutta P, Dutta D, Ghose A
Infect Immun. 1981; 32(1):1-8.
PMID: 7216479
PMC: 350577.
DOI: 10.1128/iai.32.1.1-8.1981.
Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
Cryz Jr S, Furer E, Germanier R
Infect Immun. 1982; 38(1):21-6.
PMID: 7141690
PMC: 347690.
DOI: 10.1128/iai.38.1.21-26.1982.
Development of an enzyme-linked immunosorbent assay for studying Vibrio cholerae cell surface antigens.
Cryz Jr S, Furer E, Germanier R
J Clin Microbiol. 1982; 16(1):41-5.
PMID: 7107860
PMC: 272291.
DOI: 10.1128/jcm.16.1.41-45.1982.
Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.
Pierce N, Cray Jr W, Sacci Jr J
Infect Immun. 1982; 37(2):687-94.
PMID: 6889574
PMC: 347586.
DOI: 10.1128/iai.37.2.687-694.1982.
Agglutinating and bactericidal properties of fractions of rabbit anti-Vibrio cholerae serum.
PIKE R, Chandler C
J Bacteriol. 1969; 98(3):956-62.
PMID: 5788722
PMC: 315281.
DOI: 10.1128/jb.98.3.956-962.1969.
Furazolidone in paediatric cholera.
Karchmer A, Curlin G, Huq M, Hirschhorn N
Bull World Health Organ. 1970; 43(3):373-8.
PMID: 5312991
PMC: 2427680.
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera.
McCormack W, Rahman A, Chowdhury A, Mosley W, Phillips R
Bull World Health Organ. 1969; 40(2):199-204.
PMID: 5306540
PMC: 2554602.
Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
BENENSON A, Saad A, Mosley W
Bull World Health Organ. 1968; 38(2):277-85.
PMID: 5302303
PMC: 2554323.
Serological studies in cholera. I. Vibrio agglutinin response of cholera patients determined by a microtechnique.
BENENSON A, Saad A, Paul M
Bull World Health Organ. 1968; 38(2):267-76.
PMID: 5302302
PMC: 2554308.
Vibrio parahaemolyticus and diarrhoea associated with non-cholera vibrios.
CHATTERJEE B, Gorbach S, NEOGY K
Bull World Health Organ. 1970; 42(3):460-3.
PMID: 4911683
PMC: 2427539.
The role of Peyer's patch cells in antibody formation.
Veldkamp J, van der Gaag R, Willers J
Immunology. 1973; 25(5):761-71.
PMID: 4586738
PMC: 1423050.
Radiobacteriolysis: a new technique using chromium-51 for assaying anti-Vibrio cholerae antibodies.
Blachman U, Clark W, Pickett M
Infect Immun. 1973; 7(1):53-61.
PMID: 4570279
PMC: 422638.
DOI: 10.1128/iai.7.1.53-61.1973.
Seroepidemiology of cholera in Gulf coastal Texas.
HUNT M, Woodward W, Keswick B, DuPont H
Appl Environ Microbiol. 1988; 54(7):1673-7.
PMID: 3415232
PMC: 202726.
DOI: 10.1128/aem.54.7.1673-1677.1988.
Depression of cell-mediated immunity in cholera.
PALMER D, Zaman S
Infect Immun. 1979; 23(1):27-30.
PMID: 422232
PMC: 550683.
DOI: 10.1128/iai.23.1.27-30.1979.
